A phase 2 proof of concept study of MBX-8025 in patients with Primary Biliary Cholangitis (PBC) who are inadequate responders to ursodeoxycholic acid (UDCA)

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Author(s): Jones D, Galambos MR, Swain MG, Doerffel Y, Steinberg A, Varga M, Choi YJ, Martin R, McWherter C, Chera H, Boudes P, Hirschfield GM

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: The Liver Meeting AASLD 2016

Year of Conference: 2016

Pages: 1123A-1124A

Print publication date: 01/12/2016

Online publication date: 18/11/2016

Acceptance date: 02/04/2016

ISSN: 0270-9139

Publisher: John Wiley & Sons, Inc.

URL: https://doi.org/10.1002/hep.28909

DOI: 10.1002/hep.28909

Series Title: Hepatology

ePrints